导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.26% | 872/4773 |
| 近一周 | -1.16% | 1744/5465 |
| 近一月 | -3.67% | 2737/5421 |
| 近一季 | -8.40% | 3256/5231 |
| 近半年 | 0.26% | 1332/4920 |
| 近一年 | 13.28% | 896/4394 |
| 近两年 | 66.62% | 1074/2954 |
| 近三年 | 30.60% | 1071/2253 |
| 成立以来 | 41.33% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.28% 763/4961 |
24.92% 1048/5312 |
- - |
- - |
| 2025 | 23.75% 1844/4813 |
2.04% 1487/3635 |
4.24% 820/4076 |
13.50% 2987/4524 |
2.51% 926/4813 |
| 2024 | 4.36% 1880/3463 |
-2.20% 1331/2808 |
-3.21% 1322/3014 |
11.24% 2536/3129 |
-0.89% 1538/3463 |
| 2023 | -13.13% 1524/2656 |
2.48% 1344/2280 |
-4.26% 1104/2385 |
-4.34% 1116/2515 |
-7.46% 2156/2655 |
| 2022 | -19.65% 878/2207 |
-15.65% 1057/1919 |
4.29% 1027/2016 |
-9.63% 293/2113 |
1.06% 1398/2208 |
| 2021 | 16.79% 257/1822 |
-3.68% 821/1255 |
11.15% 394/1330 |
4.12% 380/1466 |
4.76% 315/1822 |
| 2020 | - - |
- - |
- - |
8.35% 720/1164 |
5.23% 797/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 平安中证500指数增强A VS. 长安沪深300非周期A(740101) |